A Novel Strategy for Development of Recombinant Antitoxin Therapeutics Tested in a Mouse Botulism Model

Antitoxins are needed that can be produced economically with improved safety and shelf life compared to conventional antisera-based therapeutics. Here we report a practical strategy for development of simple antitoxin therapeutics with substantial advantages over currently available treatments. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukherjee, Jean, Tremblay, Jacqueline M., Leysath, Clinton E., Ofori, Kwasi, Baldwin, Karen, Feng, Xiaochuan, Bedenice, Daniela, Webb, Robert P., Wright, Patrick M., Smith, Leonard A., Tzipori, Saul, Shoemaker, Charles B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253120/
https://www.ncbi.nlm.nih.gov/pubmed/22238680
http://dx.doi.org/10.1371/journal.pone.0029941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253120/
https://www.ncbi.nlm.nih.gov/pubmed/22238680
http://dx.doi.org/10.1371/journal.pone.0029941

Ejemplares similares